Vertex Pharmaceuticals in House members’ stock disclosures
VRTXVertex Pharmaceuticals Incorporated. Ticker VRTX.
Rows tied to the company by exact company name (22, scanned filings); exact ticker (10, filings with a text layer); exact ticker (2, scanned filings).
Window: 119th Congress, from January 3, 2025. Data as of November 15, 2026.
Stock trade data comes from Periodic Transaction Reports (PTRs) filed with the Office of the Clerk, U.S. House of Representatives under the STOCK Act.
Data: House Clerk Financial Disclosures. Data as of November 15, 2026.
Where we looked: House stock disclosures, for the trades on this page, and FEC records of PAC giving to House members, for the company PAC linked below.
Owner as filed
| Owner | Purchases | Sales | Exchanges | Options | All |
|---|---|---|---|---|---|
| Self | 3 | 4 | 0 | 0 | 7 |
| Spouse | 9 | 9 | 0 | 0 | 18 |
| Dependent Child | 6 | 3 | 0 | 0 | 9 |
Every trade
| Trade date | Notified | Filed | Member | Owner | Type | Amount | Asset | |
|---|---|---|---|---|---|---|---|---|
| 2026-10-07 | 2026-11-02 | 2026-11-05 | Ro Khanna (D-CA-17) | Spouse | Sale (Partial) | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2026-09-04 | 2026-10-01 | 2026-10-07 | Ro Khanna (D-CA-17) | Spouse | Purchase | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2026-08-26 | 2026-09-03 | 2026-09-05 | David J. Taylor (R-OH-2) | Self | Sale | $1,001 - $15,000 | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) VRTX | |
| 2026-06-02 | 2026-07-01 | 2026-07-06 | Ro Khanna (D-CA-17) | Dependent Child | Purchase | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2026-05-27 | 2026-06-08 | 2026-06-09 | Ro Khanna (D-CA-17) | Spouse | Sale | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2026-04-24 | 2026-05-04 | 2026-05-11 | Ro Khanna (D-CA-17) | Spouse | Purchase | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2026-04-13 | 2026-05-04 | 2026-05-11 | Ro Khanna (D-CA-17) | Spouse | Purchase | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2026-03-30 | 2026-04-02 | 2026-04-07 | Ro Khanna (D-CA-17) | Dependent Child | Sale (Partial) | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2026-03-23 | 2026-04-02 | 2026-04-07 | Ro Khanna (D-CA-17) | Spouse | Purchase | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2026-02-05 | 2026-03-04 | 2026-03-09 | Ro Khanna (D-CA-17) | Spouse | Sale | $15,001 - $50,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2026-01-29 | 2026-01-30 | 2026-02-02 | David J. Taylor (R-OH-2) | Self | Sale | $1,001 - $15,000 | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) VRTX | |
| 2026-01-29 | 2026-02-03 | 2026-02-06 | Ro Khanna (D-CA-17) | Spouse | Purchase | $15,001 - $50,000 | VERTEX PHARMACEUTICALS INCORPORATED CMN | |
| 2026-01-23 | 2026-02-03 | 2026-02-06 | Ro Khanna (D-CA-17) | Dependent Child | Purchase | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2025-10-07 | 2025-11-04 | 2025-11-06 | Ro Khanna (D-CA-17) | Spouse | Purchase | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2025-09-29 | 2025-10-02 | 2025-10-03 | Ro Khanna (D-CA-17) | Dependent Child | Purchase | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2025-09-05 | 2025-10-02 | 2025-10-03 | Ro Khanna (D-CA-17) | Spouse | Purchase | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2025-08-26 | 2025-09-04 | 2025-09-09 | Ro Khanna (D-CA-17) | Dependent Child | Sale | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2025-08-07 | 2025-08-19 | 2025-09-02 | David J. Taylor (R-OH-2) | Self | Purchase | $1,001 - $15,000 | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) VRTX | |
| 2025-08-04 | 2025-09-04 | 2025-09-09 | Ro Khanna (D-CA-17) | Spouse | Purchase | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2025-06-23 | 2025-07-07 | 2025-07-09 | Ro Khanna (D-CA-17) | Dependent Child | Purchase | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2025-06-11 | 2025-08-13 | 2025-08-13 | Lisa C. McClain (R-MI-9) | Spouse | Sale | $1,001 - $15,000 | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) VRTX | |
| 2025-06-10 | 2025-08-13 | 2025-08-13 | Lisa C. McClain (R-MI-9) | Spouse | Sale (Partial) | $1,001 - $15,000 | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) VRTX | |
| 2025-05-28 | 2025-06-09 | 2025-06-10 | Ro Khanna (D-CA-17) | Spouse | Sale (Partial) | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2025-05-19 | 2025-06-09 | 2025-06-10 | Ro Khanna (D-CA-17) | Dependent Child | Sale | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2025-05-12 | 2025-05-15 | 2025-06-22 | Jefferson Shreve (R-IN-6) | Self | Sale | $15,001 - $50,000 | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) VRTXAccount Closing | |
| 2025-04-23 | 2025-05-08 | 2025-05-12 | Ro Khanna (D-CA-17) | Spouse | Purchase | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2025-03-20 | 2025-04-07 | 2025-04-14 | Byron Donalds (R-FL-19) | Self | Sale | $1,001 - $15,000 | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) VRTX | |
| 2025-03-20 | 2025-04-07 | 2025-04-14 | Byron Donalds (R-FL-19) | Spouse | Sale | $1,001 - $15,000 | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) VRTX | |
| Date unclear | — | 2025-04-11 | Jefferson Shreve (R-IN-6) | Self | Purchase | $15,001 - $50,000 | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) VRTXPortfolio Rebalance | |
| 2025-02-25 | 2025-03-05 | 2025-03-06 | Ro Khanna (D-CA-17) | Dependent Child | Purchase | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN VRTX | |
| 2025-02-24 | 2025-03-01 | 2025-03-09 | Jefferson Shreve (R-IN-6) | Self | Purchase | $15,001 - $50,000 | Vertex Pharmaceuticals Incorporated - Common Stock (VRTX) VRTXPortfolio Rebalance | |
| 2025-02-19 | 2025-03-05 | 2025-03-06 | Ro Khanna (D-CA-17) | Spouse | Sale (Partial) | $1,001 - $15,000 | VERTEX PHARMACEUTICALS INCORPO CMN | |
| 2025-01-22 | 2025-02-04 | 2025-02-06 | Ro Khanna (D-CA-17) | Dependent Child | Purchase | $1,001 - $15,000 | Vertex Pharmaceuticals Incorp CMN | |
| 2025-01-17 | 2025-02-04 | 2025-02-06 | Ro Khanna (D-CA-17) | Spouse | Sale (Partial) | $1,001 - $15,000 | Vertex Pharmaceuticals Incorporated CMN VRTX |
No trades match these filters.
Context
Each table below is a separate join to this company. Each is context for the trades above and shows no cause.
Company PAC
VERTEX PHARMACEUTICALS INCORPORATED POLITICAL ACTION COMMITTEE, FEC committee C00468660. Contributions to members who are in the House now, by two-year election cycle.
| Cycle | Contributions to current members | Members |
|---|---|---|
| 2026 | $131K | 48 |
| 2024 | $66K | 24 |
| 2022 | $34K | 19 |
| 2020 | $54K | 20 |
| 2018 | $60K | 21 |
| 2016 | $34K | 19 |
| 2014 | $22K | 13 |
| 2012 | $6K | 6 |
| 2010 | $3K | 2 |
Source: Federal Election Commission bulk data (contributions from committee C00468660 to candidate committees).
Limits
House only
This page covers the House of Representatives. Senate trades are not included.
Reporting deadline
A PTR is due by the earlier of 30 days after the member is made aware of a transaction or 45 days after the transaction date. Recent trades may not yet appear on this page. PTR filings are published as PDFs; transaction details are extracted using AI-assisted document reading (Claude). Each entry links to the original PDF for verification.
Transaction amounts
The STOCK Act requires disclosure of transaction amounts as ranges (for example, “$1,001 – $15,000”). The amounts shown here reflect those ranges as reported in the original filings. Marker size groups the ranges; no dollar value is estimated.
Owner
The owner is the account holder as filed: the member, a spouse, a dependent child or a joint account. 7 of the 34 rows are in the member’s own account.
Scanned filings
24 of the 34 rows come from scanned filings, which a model reads from page images.
Options
This company has no option trades in the window.
What this page cannot show
It does not show the full list of a member’s holdings, trades before January 3, 2025, any trade not yet reported, or why a trade was made.
All data from House Clerk Financial Disclosures · Periodic Transaction Reports (PTRs) · Transaction details extracted from PDF filings using AI-assisted document reading
